| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 2 Oct 24 | ENTX Entera Bio | Ordinary Shares, par value NIS 0.0000769 per share | Grant | Acquire A | No | No | 0 | 11,269 | 0.00 | 265,491 |
| 27 Aug 24 | ENTX Entera Bio | Ordinary Shares, par value NIS 0.0000769 per share | Grant | Acquire A | No | No | 0 | 27,261 | 0.00 | 254,222 |
| 15 Jun 24 | TEVA Teva Pharmaceutical Industries Limited | Ordinary Shares | Option exercise | Acquire M | No | No | 0 | 21,108 | 0.00 | 106,025 |
| 15 Jun 24 | TEVA Teva Pharmaceutical Industries Limited | Restricted Share Units Ordinary Shares | Option exercise | Dispose M | No | No | 0 | 21,108 | 0.00 | 0 |
| 6 Jun 24 | TEVA Teva Pharmaceutical Industries Limited | Restricted Share Units Ordinary Shares | Grant | Acquire A | No | No | 0 | 9,632 | 0.00 | 9,632 |
| 1 Jan 24 | ENTX Entera Bio | Stock Option Ordinary Shares, par value NIS 0.0000769 per share | Grant | Acquire A | No | No | 0.6 | 108,333 | 65.00 k | 108,333 |
